Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study

Background/Aims The efficacy and safety of vedolizumab in moderate to severely active ulcerative colitis (UC) have been demonstrated in the GEMINI 1 study (NCT00783718). This post-hoc exploratory analysis sought to establish the efficacy and safety of vedolizumab in a subgroup of patients from Asian...

Full description

Bibliographic Details
Main Authors: Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2021-01-01
Series:Intestinal Research
Subjects:
vedolizumab
colitis, ulcerative
asia
remission induction
clinical efficacy
Online Access:http://www.irjournal.org/upload/pdf/ir-2019-09159.pdf

Internet

http://www.irjournal.org/upload/pdf/ir-2019-09159.pdf

Similar Items